Translations:Research/nci-role/bioinformatics/4/en

The return on investment from aggregating and sharing research data is particularly high for rare cancers, such as those that occur in children.

NCI's Rare Clinics Fostering Collaboration

Mining the sheer volume of "big data" to answer the complex biological questions that will bring precision medicine into the mainstream of clinical care, however, remains a challenge. Nowhere is this challenge more evident than in oncology, as much of these data will come from studies of patients with cancer.